Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

The proposal should be withdrawn. It is untethered to the Inflation Reduction Act and science and undercuts the incentive to ...

Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant ...

That committee oversees Medicaid, which is funded through a federal and state partnership. Jessica Hall is a retirement reporter for MarketWatch. She was an Age Boom Academy Fellow with Columbia ...

This could force many local pharmacies to choose between stocking critical medications or keeping their doors open.

Drugmaker AstraZeneca tells Politico that it plans to participate in negotiations with CMS over the price Medicare pays for Farxiga, a drug used to treat type 2 diabetes, as well as heart failure and ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

History has shown us how government-imposed prices end badly for ... the law essentially “broke” Medicare Part D. What has been billed as a good-faith negotiation between the government ...

and Peter Welch (D-VT) to introduce the Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act. The legislation would expand the number of drugs that Medicare can negotiate lower drug ...

announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has agreed to pay for certain expenses incurred by medical centers treating patients covered by Medicare or Medicaid ...

On a recent episode of CNN’s State of the Union, Louisiana Republican U.S. House Speaker Mike Johnson made a bold and necessary statement: more than 1.4 million people illegally in the country are ...